ADVERTISEMENT

Gilles Montalescot, MD, PhD

Original Contribution

One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study

07/25/2017

Alexander JJ. IJsselmuiden , MD, PhD;

Rainer Wessely , MD, PhD;

Thomas Dengler , MD;

Johanne Silvain , MD, PhD;

Joanna J. Wykrzykowska , MD, PhD;

Gilles Montalescot , MD, PhD;

Jan G.P. Tijssen , PhD;

Rene Spaargaren , MD;

Giovanni Amoroso , MD, PhD;

Karel T. Koch , MD, PhD;

Robbert J. de Winter , MD, PhD;

Alessio La Manna , MD;

Robert Jan van Geuns , MD, PhD;

Maik J. Grundeken , MD;

Huangling Lu , MD;

Nicola S. Vos , MD;

We investigated outcomes in STEMI patients after Stentys treatment for bifurcation culprit lesions.

We investigated outcomes in STEMI patients after Stentys treatment for bifurcation culprit lesions.

We investigated outcomes in...

07/25/2017

Journal of Invasive Cardiology

Farjat-Pasos Embolism Table 1

Original Contribution

Transcatheter Closure of Patent Foramen Ovale in Patients With Peripheral (Noncerebrovascular) Embolism

09/23/2022

Josep Rodés-Cabau , MD, PhD;

Paul Guedeney , MD;

Julio I. Farjat-Pasos , MD, MSc;

Christine Houde , MD;

Jules Mesnier , MD;

Alberto Alperi , MD, PhD;

Melanie Côté , MD, MSc;

Gilles Montalescot , MD, PhD;

Scarce data exist on noncerebrovascular peripheral embolism (NCPE) patients undergoing transcatheter patent foramen ovale (PFO) closure. The objectives of this study were to determine the clinical and procedural characteristics, and long-term...

Scarce data exist on noncerebrovascular peripheral embolism (NCPE) patients undergoing transcatheter patent foramen ovale (PFO) closure. The objectives of this study were to determine the clinical and procedural characteristics, and long-term...

Scarce data exist on...

09/23/2022

Journal of Invasive Cardiology

Original Contribution

Safety of Very Early Sheath Removal in Patients Treated With REG1 for Acute Coronary Syndromes: Insights From the RADAR Trial

10/31/2013

Jan H. Cornel , MD;

Richard C. Becker , MD;

John H. Alexander , MD, MHS;

Roxana Mehran , MD;

John P. Vavalle , MD;

Mauricio G. Cohen , MD, FACC;

Thomas J. Povsic , MD, PhD;

Christopher E. Buller , MD, FRCPC, FACC;

Steven L. Zelenkofske , DO;

Laura H. Aberle , BSPH;

Jaroslaw D. Kasprzak , MD;

Gilles Montalescot , MD, PhD;

Christoph Bode , MD;

Anticoagulation with REG1 allows for very early arterial sheath removal following cardiac catheterization without increasing the time to hemostasis or vascular access-site bleeding complications. Further studies are needed to determine...

Anticoagulation with REG1 allows for very early arterial sheath removal following cardiac catheterization without increasing the time to hemostasis or vascular access-site bleeding complications. Further studies are needed to determine...

Anticoagulation with REG1 allows...

10/31/2013

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 6 ⁠–⁠ November 8

NEI Congress

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

WoundCon

November 8

Dermatology Week

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Advertisement

Advertisement